Penumbra, Inc. reported U.S. commercial availability of the Penumbra System’s most advanced technology, the Penumbra JET 7 Reperfusion Catheter with XTRA FLEX technology, at the Society of NeuroInterventional Surgery (SNIS) 16th Annual Meeting in Miami. Penumbra JET 7 with XTRA FLEX technology is used with the Penumbra ENGINE™ in the fully integrated Penumbra System® – an aspiration-based mechanical thrombectomy system that enables physicians to extract thrombus in acute ischemic stroke patients.
The Penumbra JET 7 Reperfusion Catheter with XTRA FLEX technology is the latest advancement in the Penumbra System JET – ENGINE family of products, which was launched last September. As the Penumbra System’s eighth generation reperfusion catheter for proximal large vessel occlusions, the catheter is designed for advanced trackability and navigation, and maintains the large 0.072” lumen. Penumbra JET 7 with XTRA FLEX technology, together with the power of the Penumbra ENGINE, are designed to maximize thrombus removal force.
Initial clinical experience with the Penumbra JET 7 with XTRA FLEX technology will be shared today from 12:45-1 p.m. Eastern Daylight Time in the Industry Technology Luncheon Symposium by Donald F. Frei, M.D., director of Neuro-Interventional Surgery, Swedish Medical Center, Englewood, Colorado.
Penumbra booth #614, in the exhibit hall, will feature the Penumbra JET 7 with XTRA FLEX technology and Penumbra ENGINE, together with the company’s broad range of access and embolization products. In addition, MVI Health Inc., a Penumbra subsidiary, will also be exhibiting at the meeting.